The price of hesitation

European governments face mounting budget pressures and must decide whether to invest in healthcare innovation or risk long-term economic consequences. The cost of inaction, such as lost productivity and chronic diseases, is estimated to be up to €282 billion annually due to cardiovascular diseases alone. Investing in health innovation is seen as crucial for Europe's economic strength and global relevance.

Summarized from the sources above. Read the originals for the full story.